In addition, CD117 is overexpressed in OCSCs and mediates both tumor-initiating capacity and chemoresistance to cisplatin/paclitaxel by activating the Wnt/β-catenin-ABCG2 axis [46]. The gene discussed is ABCG2; the disease is neoplasm.